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National Institutes of Health, Grant numbers: R01 MH087636-01A1, PO1-HD070454, 1U01MH101720-02; Chulalongkorn Academic Advancement Into Its 2nd Century Project; Government of Abu Dhabi to the Children's National Health System 22q11.2 deletion syndrome (22q11.2 DS) is the most common microdeletion syndrome and is underdiagnosed in diverse populations. This syndrome has a variable phenotype and affects multiple systems, making early recognition imperative. In this study, individuals from diverse populations with 22q11.2 DS were evaluated clinically and by facial analysis technology. Clinical information from 106 individuals and images from 101 were collected from individuals with 22q11.2 DS from 11 countries; average age was 11.7 and 47% were male. Individuals were grouped into categories of African descent (African), Asian, and Latin American. We found that the phenotype of 22q11.2 DS varied across population groups. Only two findings, congenital heart disease and learning problems, were found in greater than 50% of participants. When comparing the clinical features of 22q11.2 DS in each population, the proportion of individuals within each clinical category was statistically different except for learning problems and ear anomalies (P < 0.05). However, when Africans were removed from analysis, six additional clinical features were found to be independent of ethnicity (P ≥ 0.05). Using facial analysis technology, we compared 156 Caucasians, Africans, Asians, and Latin American individuals with 22q11.2 DS with 156 age and gender matched controls and found that sensitivity and specificity were greater than 96% for all populations. In summary, we present the varied findings from global populations with 22q11.2 DS and demonstrate how facial analysis technology can assist clinicians in making accurate 22q11.2 DS diagnoses. This work will assist in earlier detection and in increasing recognition of 22q11.2 DS throughout the world. syndrome with an estimated prevalence of 1:3000 to 1:6000 children and 1:1000 unselected fetuses (Botto et al., 2003; Grati et al., 2015; McDonald-McGinn et al., 2015; Wapner et al., 2012) . This condition is characterized by congenital heart disease (especially conotruncal defects), immunodeficiency, hypoparathyroidism, palatal, gastrointestinal, skeletal and renal abnormalities, characteristic facial features, developmental and speech delay, and an increased risk for psychiatric illness; early recognition is imperative (McDonald-McGinn, Emanuel, & Zackai, 1993; Oskarsdottir, Persson, Eriksson, & Fasth, 2005) . Clinical presentation varies by age and is often due to clinical suspicion based on multiple findings; however, the phenotype is variable and different ethnicities may make the diagnosis more difficult (McDonald-McGinn et al., 2015) .
Most studies to date have focused on individuals of European descent and investigators have found the diagnosis more difficult in diverse populations (Liu et al., 2014; McDonald-McGinn et al., 2005; Veerapandiyan et al., 2011) . Two groups have found the craniofacial dysmorphisms in African Americans to be different than the standard recognized anomalies found in Caucasians (McDonald-McGinn et al., 2005; Veerapandiyan et al., 2011) . In a large Chinese adult population with conotruncal defects, facial features of individuals with 22q11.2 DS were under-recognized and 22q11.2 DS was under-diagnosed (Liu et al., 2014) . Liu et al. (2014) found that in every 10 adult patients with conotruncal anomalies, 1 previously unrecognized diagnosis of 22q11.2 DS was present. Another group studying Chinese individuals found that all 43 of their study participants with 22q11.2 DS had typical facial findings consisting of a vertically long face, narrow palpebral fissures, fleshy nose with a broad nasal root, flattened malar region, retrognathia, and overfolded helix; however, this was not a prospective study and it is difficult to determine if these findings would have been made without knowing the molecular diagnosis (Wu et al., 2013) .
Clinical descriptions of Latin Americans is scarce; one large study of 208 patients described multi-systemic anomalies in a Chilean population but did not include facial features (Repetto et al., 2009 (De Decker et al., 2016; Grassi et al., 2014; Liu et al., 2014; Uwineza et al., 2014; Veerapandiyan et al., 2011 
| Facial analysis technology
As previously described (Kruszka et al., 2017) , digital facial analysis technology (Cerrolaza et al., 2016; Zhao et al., 2013; Zhao, Okada, et al., 2014; Zhao, Werghi, et al., 2014) was used to evaluate the 156 individuals with 22q11.2 DS from this study. Additionally, we used healthy controls from our previously described database (Zhao, Okada, et al., 2014; Zhao et al., 2013) . Cases and controls were matched by ethnicity, age, and gender. Only frontal images were analyzed by this technology.
Using the images of our study participants as input to our algorithms, output consisted of feature extraction, feature selection, and classification. After face detection and landmark positioning, as explained in Zhao, Okada, et al., (2014) , a set of 126 facial features, including both geometric and texture biomarkers, were extracted. The geometric biomarkers consisted of a set of distances and angles calculated between the different inner facial landmarks, as represented in Figure 1 . As robust markers of monotonic illumination changes, local binary patterns (Ojala, Pietikäinen, & Harwood, 1996) were calculated at each of the 33 inner facial landmarks to quantify texture information information was used to create optimal landmark-specific texture features, as presented in Cerrolaza et al. (2016) . From the collection of geometric and texture features, the most significant ones were selected using the method proposed previously (Cai, Zhang, & He, 2010) . For each feature set, a support vector machine classifier (Cortes & Vapnik, 1995) was trained using a leave-one-out cross-validation strategy (Elisseeff & Pontil, 2003) . The optimal number of features was selected as the one that maximized the classification accuracy. As an estimator of the individual discriminant power of each feature selected, the P-value of each feature was also estimated using the Student's t-test.
Significance between methods used to detect 22q11.2 DS was assessed using Fisher's exact test.
| RESULTS
Clinical information was collected on 106 individuals and photo images were collected from 101 individuals with 22q11.2 DS from 11 countries; average age was 11.7 years (range newborn to 43 years; SD = 10.1 years) and 47% were male (Supplementary Table S1 ); 10 of these individuals had been published previously (Liu et al., 2014; Uwineza et al., 2014) . Additionally, 26 images from the medical literature were added to make a total of 127 images (Figures 2-4) . Table 1 shows exam findings in our study and the medical literature stratified by population. The clinical features of 22q11.2 DS described previously (McDonald-McGinn et al., 1993; Oskarsdottir, Holmberg, Fasth, & Stromland, 2008; Oskarsdottir et al., 2005) are listed in Table 1 .
In both this study and the medical literature, clinical findings are varied. Only two findings in the present study, congenital heart disease and learning problems, were found in greater than 60% of participants. In the medical literature, most but not all studies reported a majority of participants with congenital heart disease ( (2011) found 22% of African Americans to have narrow palpebral fissures.
Independent of population studied (P = 0.15), ear anomalies were common in our cohort and other studies examined in Table 1 with anomalies ranging from 64% to 91% except for the Grassi et al. (2014) study that found only 48% of their Brazilian cohort to have ear findings.
A more objective evaluation using facial analysis technology, FIGURE 4 Frontal and lateral facial profiles of Latin Americans with 22q11.2 deletion syndrome. Gender, age, and country of origin found in Supplementary Table S1 .
e Reprinted from Grassi et al. (2014) .
at seven and the Asian and Latin American groups each at 9 (Supplementary Tables S2 and S5 ). The African and Asian groups were most similar, sharing six significant geometric features that were different from their, respectively, matched controls including:
telecanthus, short palpebral fissures, angle at nose root, increased upper lip width, increased angle of ala of the nose, and decreased distance between oral commissures (narrow mouth).
Sensitivity, specificity and diagnostic accuracy were 0.833, 0.859, and 0.846, respectively for a combined analysis of the entire cohort (n = 156 cases; n = 156 controls) using only geometric features (Table 3) . However, when using both geometric and texture measures, sensitivity increased to 0.962, specificity to 0.936 and accuracy to 0.949 (P ≤ 0.001 for all, Table 3 ). All four population groups (Caucasian, African, Asian, and Latin American) cohort, the number of clinical features that were present in similar ratios across ethnicities (P ≥ 0.05) increased from two to eight.
Subjective exam findings such as those shown in Table 1 are difficult to compare due to differences in examiners and reported outcomes, making an objective strategy such as facial analysis technology more attractive. As our second conclusion, we found that digital facial technology also finds differences between population groups. Interestingly, the facial analysis data also recognized one population group that was different, but it was the Caucasian cohort.
All four groups (Caucasian, African, Asian, and Latin American) only shared two common geographic facial analysis features: telecanthus and narrow palpebral fissures (Supplementary Tables S2-5 ). However, if the Caucasian cohort was removed, the other three groups shared four geographic features including telecanthus, short palpebral fissures, angle of the ala of the nose, and narrow mouth.
The final and possibly the most important conclusion of this study is the accuracy of digital facial technology which we propose as an alternative to cytogenetic/molecular testing in diverse populations when laboratory studies are not available. The sensitivity of facial analysis technology is equal to or greater than 96.6% for each diverse population, and specificity is equal to greater than 96.3% (Table 3) .
When using a scoring system designed from a European cohort (Oskarsdottir et al., 2005) , De Decker et al. (2016) positive predictive value of 55% using the sensitivity and specificity found in Table 3 , a fourfold increase over the diagnostic criteria used in their study (De Decker et al., 2016) . As noted above, Liu et al. (2014) found that one individual with 22q11.2 DS goes undiagnosed for every 10 individuals in their cohort of Chinese adults with conotruncal heart defects. Using the prevalence in Liu et al., (2014) cohort and the sensitivity and specificity in Table 3 for the Asian cohort, the positive predictive value of facial analysis technology would have been 78%
and the high sensitivity of our assay would have picked up all cases of 22q11.2 DS in their study. The accuracy of digital facial analysis technology is already well known in Down syndrome (Kruszka et al., 2017; Zhao, Okada, et al., 2014) , and with the wide spread availability of hand held devices throughout the world, this study proposes the use of this technology across diverse populations.
The ethical implications of associating genetic diagnoses with diverse populations are potentially a source of disconcert for some, especially when considering historical concerns about the association of biological classifications and racial and ethnic categories. These issues have been reviewed in depth (Koretzky et al., 2016) and are considered beyond the scope of this study.
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